Eisai
4523.T
#2391
Rank
โ‚น761.79 B
Marketcap
โ‚น2,699
Share price
0.70%
Change (1 day)
19.65%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น83.66. In 2026 the company made an earnings per share (EPS) of โ‚น83.30 a decrease over its 2025 EPS that were of โ‚น105.49.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น83.30-21.04%
2025โ‚น105.4911.85%
2024โ‚น94.32-32.63%
2023โ‚น140.005.52%
2022โ‚น132.67-74.01%
2021โ‚น510.43-66.58%
2020โ‚น1,52798.24%
2019โ‚น770.3217.01%
2018โ‚น658.3337.78%
2017โ‚น477.82-27.62%
2016โ‚น660.1835.33%
2015โ‚น487.83-2.82%
2014โ‚น502.00-27.66%
2013โ‚น693.98-27.49%
2012โ‚น957.12-12.67%
2011โ‚น1,09688.08%
2010โ‚น582.75-11.06%
2009โ‚น655.24-390.15%
2008-โ‚น225.83-127.78%
2007โ‚น813.03347.11%
2006โ‚น181.844.38%
2005โ‚น174.227.4%
2004โ‚น162.2243.03%
2003โ‚น113.4225.09%
2002โ‚น90.6752.67%
2001โ‚น59.3969.76%
2000โ‚น34.98